Retour
Fourchette du Jour
4,15 €
4,42 €
Fourchette 52 Semaines
0,40 €
8,21 €
Volume
5 408 358
Moyenne 50J / 200J
5,24 €
/
3,55 €
Clôture Précédente
4,46 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -41,6 | 0,4 |
| P/B | 7,3 | 2,9 |
| ROE % | -35,3 | 3,7 |
| Net Margin % | -22,8 | 3,9 |
| Rev Growth 5Y % | 19,5 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
11,60 €
+173.6%
Low: 10,00 €
High: 16,00 €
BPA Prévisionnel
-0,47 €
CA Est.
21 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
0,04 €
0,00 € – 0,15 €
|
200 M | 1 |
| FY2029 |
-0,46 €
-1,66 € – -0,03 €
|
56 M | 1 |
| FY2028 |
-0,43 €
-0,68 € – -0,29 €
|
38 M | 5 |
Points Clés
Revenue grew 19,54% annually over 5 years — strong growth
Earnings declined -154,50% over the past year
Debt/Equity of 0,04 — conservative balance sheet
Negative free cash flow of -75,81M
PEG of 0,24 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 64,36%
Croissance
Revenue Growth (5Y)
19,54%
Revenue (1Y)-44,82%
Earnings (1Y)-154,50%
FCF Growth (3Y)N/A
Qualité
Return on Equity
-35,25%
ROIC-14,21%
Net Margin-22,79%
Op. Margin-25,67%
Sécurité
Debt / Equity
0,04
Current Ratio3,09
Interest Coverage0,00
Valorisation
P/E Ratio
-41,55
P/B Ratio7,29
EV/EBITDAN/A
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -44,82% | Revenue Growth (3Y) | -13,23% |
| Earnings Growth (1Y) | -154,50% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 19,54% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 76,20M | Net Income (TTM) | -17,37M |
| ROE | -35,25% | ROA | -11,46% |
| Gross Margin | 100,00% | Operating Margin | -25,67% |
| Net Margin | -22,79% | Free Cash Flow (TTM) | -75,81M |
| ROIC | -14,21% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,04 | Current Ratio | 3,09 |
| Interest Coverage | 0,00 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | -41,55 | P/B Ratio | 7,29 |
| P/S Ratio | 9,47 | PEG Ratio | 0,24 |
| EV/EBITDA | N/A | Dividend Yield | 0,01% |
| Market Cap | 721,59M | Enterprise Value | 713,16M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 76,20M | 138,10M | 101,21M | 53,16M | 37,31M |
| Net Income | -17,37M | 31,87M | -569 000,0 | -99,32M | -115,87M |
| EPS (Diluted) | -0,15 | 0,38 | -0,01 | -1,48 | -1,26 |
| Gross Profit | 76,20M | 138,10M | 101,21M | 53,16M | 37,31M |
| Operating Income | -19,56M | 25,00M | -6,48M | -101,34M | -116,04M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 151,57M | 120,53M | 201,79M | 260,89M | 339,41M |
| Total Liabilities | 52,56M | 120,99M | 249,24M | 346,64M | 339,87M |
| Shareholders' Equity | 99,01M | -456 000,0 | -47,45M | -85,75M | -459 000,0 |
| Total Debt | 4,24M | 9,39M | 13,97M | 18,06M | 21,67M |
| Cash & Equivalents | 12,67M | 38,05M | 17,17M | 193,65M | 205,53M |
| Current Assets | 143,92M | 107,31M | 182,94M | 237,10M | 310,30M |
| Current Liabilities | 46,62M | 85,77M | 155,91M | 152,61M | 77,87M |